CIMdata PLM Industry Summary Online Archive
18 August 2008
Product News
Conformia Integrates SOA-Based Product/Process Lifecycle Management Into IBM Platform for Pharmaceutical Development
Conformia, supplier of enterprise solutions for product/process lifecycle management (PPLM) for regulated process manufacturing industries, announced it has integrated its solution into the IBM platform to provide an end-to-end solution for drug development to the pharmaceutical industry. The solution incorporates service oriented architecture (SOA) capabilities that have been validated by IBM. Conformia's SOA approach enables other applications running on the IBM stack and infrastructure to exchange crucial pharmaceutical data with Conformia's products. Furthermore, data from non-IBM products can now be integrated into Conformia and IBM product stacks creating the first commercial off-the-shelf, integrated information environment solution for pharmaceutical and biotech drug development.
Conformia fulfilled the IBM PartnerWorld® SOA validation criteria for their solution in December, and is working with IBM to deliver both the strategic business transformation and the commercial off-the-shelf software systems that pharmaceutical developers need to support sustainability of their transformation strategies. With the Conformia SOA platform, drug developers will be able to reduce development lifecycles, increase operational visibility and traceability, improve product quality, and decrease the costs associated with regulatory non-compliance -- all while achieving major gains in data integration.
Working together, Conformia and IBM provide the pharmaceutical industry with enterprise software on a reliable technology stack that links data around early experiments, pilot plant scale-up as well as full-scale manufacturing, along with proven business processes and deployment capabilities.
"As one of the most heavily regulated and complex industries, the pharmaceutical sector presents a myriad of unique challenges to organizations during their product-development lifecycles, and, until now, few have stepped forward to help," said Dan Pelino, general manager, IBM Global Healthcare and Life Sciences. "Together, Conformia and IBM are helping to deliver a clear path for these organizations to follow -- one that allows them to create an integrated data and information environment resulting in more effective knowledge-management programs, which they are now demanding."
"Combining our deep pharmaceutical and biotech expertise with IBM's strength in pharmaceutical industry business transformation delivers a groundbreaking new approach to help companies implement new development strategies such as the Quality by Design Paradigm or the ICH Quality Vision. This helps solve some of the biggest issues in drug development," said Anjali Kataria, founder and chief marketing officer of Conformia. "Our work with IBM both validates and strengthens our continued dedication to making product development more efficient so scientific leadership can do more with the same resources."
Become a member of the CIMdata PLM Community to receive your daily PLM news and much more.
Tell us what you think of the CIMdata Newsletter. Send your feedback.
CIMdata is committed to your privacy. Your personal information will never be sold or shared outside of CIMdata without your express permission.